Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

British National Formulary BNF

The committee classified products subject to monographs in the British Pharmacopoeia (BP), British Pharmaceutical Codex (BPC) and the British National Formulary (BNF) as Category M-Products. Acceptable products other than monograph preparations were Category A-Products. All other products were Category B-Products, these were considered less effective or more toxic than those in Categories M or A or their efficacy was regarded as unproven. [Pg.710]

The greatest influence on doctors to prescribe well is the provision of high quality information. This has been achieved over the last decades by the British National Formulary BNF. [Pg.716]

British Medical Association and Royal Pharmaceutical Society of Great Britain. (1991, September). British national formulary (BNF). London Pharmaceutical Press. Brodal, A. (1969). Neurological anatomy. New York Oxford University Press. [Pg.473]

Asthma is managed in a stepwise approach using the British Thoracic Society and Scottish Intercollegiate Guidelines Network (2008). Details are available in the British National Formulary (BNF). [Pg.64]

British National Formulary (BNF) Edition 51, 2006, Pharmaceutical Press, London. [Pg.518]

Sometimes the British National Formulary (BNF) [1] or the Summary of Product Characteristics (SPC) endorses the use of a drug in patients with liver disease. This is often sufficient and no further research is required. Fiowever, ensure that you also check the adverse effects of the drug, as these may preclude its use in some patients, even if there are no explicit contraindications or precautions regarding liver disease in the SPC. [Pg.153]

The British National Formulary (BNF) recommends that fibrates or nicotinic acid should not be combined with statins because of the potential for myopathy and rhabdomyolysis with this combination [54]. This is widely discussed in the medical literature. Numerous deaths have been reported and the high mortality associated with concurrent use of cerivastatin and gemfibrozil was partly instrumental in the decision to withdraw cerivastatin from the market in 2001 [34]. It appears that the high mortality in patients using concurrent gemfibrozil and cerivastatin was due to interactions at the level of glucuronidation, CYP2C8 inhibition and OATP inhibition [17, 55]. [Pg.246]

Prescriptions of pure drugs or of formulations from the British National Formulary (BNF) are satisfactory for almost all purposes. The composition of many of the preparations in the BNF is laid down in official pharmacopoeias, e.g. British Pharmacopoeia (BP). There are also many national and international pharmacopoeias. [Pg.33]

AMH was initially modeled on the British National Formulary (BNF), and evolved to incorporate further comparative and therapeutic information. The best available evidence is used to support recommendations, thus discouraging drug use where evidence is lacking or poor. [Pg.75]

The Misuse of Drags Act 1971 relates to the manrrfacture, supply and possession of Controlled Drags . Drags are ascribed to one of three classes based on the perceived harmfulness when they are misused the penalties are set accordingly. (See the British National Formulary BNF, for the complete listing.)... [Pg.115]

Joint Formulary Committee (1993). British National Formulary, BNF Number 25. London, UK British Medical Association and Pharmaceutical Society of Great Britain. [Pg.493]

Many adverse reactions are well known. Information about them can be found in patient information leaflets supplied with medicines, in the Monthly Index of Medical Specialties MIMS) or in the British National Formulary (BNF). However, not all patients will suffer all possible adverse reactions. Knowledge of family history can help predict who will suffer from adverse reactions. It is therefore good practice when taking a patient s history to ask about incidents of adverse reactions to drugs or allergies in the family. [Pg.30]

In 1994, district nurses, midwives and health visitors were allowed to prescribe from a limited formulary of dressings, appliances and some medicines until extended formulary nurse prescribing was introduced in 2002. This allowed registered nurses to prescribe from the nurse prescribers extended formulary, which included treatment for minor ailments, minor injuries, health promotion and palliative care. This formulary was gradually expanded over the next few years and listed in the British National Formulary BNF). [Pg.279]

Tables with length, weight and body stuface of children of different ages with normal proportions [6] are convenient when one does not have the length and weight of the child. The British National Formulary (BNF) for Children in the UK also has tables for guidance, using the Boyd equation [10]. Finally the result has to be rounded to a practical strength for the product to be prepared. Tables with length, weight and body stuface of children of different ages with normal proportions [6] are convenient when one does not have the length and weight of the child. The British National Formulary (BNF) for Children in the UK also has tables for guidance, using the Boyd equation [10]. Finally the result has to be rounded to a practical strength for the product to be prepared.
Ward DJ, Slade A, Genus T, Martino 01, Stevens AJ (2014) How innovative are new drugs launched in the UK A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012. BMJ Open 4 e006235... [Pg.330]

If no response after 1-2 days, your consultant may prescribe above-British National Formulary (BNF) doses, e.g. 8-24 mg/day, monitoring closely for respiratory depression... [Pg.657]


See other pages where British National Formulary BNF is mentioned: [Pg.437]    [Pg.456]    [Pg.4]    [Pg.435]    [Pg.354]    [Pg.828]    [Pg.3]    [Pg.302]    [Pg.47]    [Pg.83]    [Pg.116]   
See also in sourсe #XX -- [ Pg.153 , Pg.154 , Pg.155 ]




SEARCH



Formularies

National Formulary

© 2024 chempedia.info